Published on 5 Jan 2025 on Benzinga · via AOL
Nano-Cap iBio Expands Obesity Program With New Antibody Using In-Licensed...
On Thursday, iBio, Inc. (NYSE:IBIO) expanded its cardiometabolic and obesity treatment development...
NYSE.IBIO price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free